The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
- Jan G D’Haese1,
- Ihsan Ekin Demir1,
- Timo Kehl1,
- Jannik Winckler1,
- Nathalia A Giese2,
- Frank Bergmann3,
- Thomas Giese4,
- Markus W Büchler2,
- Helmut Friess1,
- Mark Hartel†1 and
- Güralp O Ceyhan†1, 2Email author
© D'Haese et al.; licensee BioMed Central Ltd. 2013
Received: 18 July 2012
Accepted: 12 January 2013
Published: 16 January 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|18 Jul 2012||Submitted||Original manuscript|
|28 Aug 2012||Reviewed||Reviewer Report - Patrick Yachimski|
|29 Aug 2012||Reviewed||Reviewer Report - Thomas Griesbacher|
|18 Oct 2012||Author responded||Author comments - Guralp Ceyhan|
|Resubmission - Version 2|
|18 Oct 2012||Submitted||Manuscript version 2|
|11 Nov 2012||Reviewed||Reviewer Report - Thomas Griesbacher|
|28 Nov 2012||Reviewed||Reviewer Report - Patrick Yachimski|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|12 Jan 2013||Editorially accepted|
|16 Jan 2013||Article published||10.1186/1471-230X-13-14|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.